迈克生物 - Financials

迈克生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	2.5B	2.9B	3.6B	4.0B	3.7B	3.2B	2.7B	2.0B	1.5B	1.1B	935.0M	779.0M	606.0M	521.0M
Revenue Growth %	-12.0%	-19.7%	-9.4%	7.5%	14.9%	20.0%	36.3%	32.3%	39.8%	13.9%	20.0%	28.5%	16.3%	--
Total Revenue	2.5B	2.9B	3.6B	4.0B	3.7B	3.2B	2.7B	2.0B	1.5B	1.1B	935.0M	779.0M	606.0M	521.0M
Cost Of Revenue	1.1B	1.3B	1.7B	1.7B	1.7B	1.6B	1.3B	911.0M	683.0M	458.0M	381.0M	340.0M	266.0M	247.0M
+Gross Profit	1.4B	1.6B	2.0B	2.3B	2.0B	1.7B	1.4B	1.1B	806.0M	607.0M	554.0M	439.0M	340.0M	274.0M
Gross Margin %	55.1%	55.3%	54.2%	58.0%	53.1%	51.8%	51.8%	53.8%	54.1%	57.0%	59.3%	56.4%	56.1%	52.6%
Total Operating Cost	2.4B	2.6B	2.8B	2.8B	2.8B	2.5B	2.1B	1.5B	1.1B	774.0M	645.0M	529.0M	405.0M	367.0M
Selling Expenses	647.0M	652.0M	630.0M	636.0M	533.0M	565.0M	453.0M	332.0M	253.0M	173.0M	139.0M	96.6M	68.0M	59.2M
Admin Expenses	165.0M	184.0M	156.0M	168.0M	146.0M	151.0M	136.0M	97.8M	144.0M	110.0M	94.9M	74.1M	56.0M	51.2M
Rd Expenses	323.0M	324.0M	273.0M	207.0M	202.0M	140.0M	109.0M	87.5M	--	--	--	--	--	--
Finance Expenses	16.4M	23.3M	18.3M	57.9M	70.0M	65.1M	48.7M	13.2M	7.9M	8.0M	9.0M	2.1M	7.0M	3.9M
+Operating Income	170.0M	331.0M	817.0M	1.2B	990.0M	696.0M	598.0M	508.0M	402.0M	302.0M	293.0M	252.0M	202.0M	153.0M
Operating Margin %	6.7%	11.4%	22.6%	30.5%	26.7%	21.6%	22.3%	25.8%	27.0%	28.4%	31.3%	32.3%	33.3%	29.4%
Non Operating Income	897,300	378,100	399,700	559,200	116,300	231,000	449,200	291,200	9.9M	3.0M	1.3M	547,100	3.9M	1.2M
Non Operating Expenses	46.2M	26.2M	28.7M	27.5M	20.0M	2.9M	2.0M	6.7M	11.3M	3.0M	10.4M	10.0M	6.4M	206,300
Investment Income	2.9M	8.6M	12.1M	395,000	994,200	-58,700	2.8M	3.7M	33.9M	10.9M	2.8M	1.2M	781,900	-1.7M
Fair Value Change Income	2.1M	-7.1M	-9.1M	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-6.7M	-4.2M	-4.1M	-4.0M	942,100	47,100	421,200	-2.7M	-966,800	--	--	--	--	--
Asset Impairment Loss	101.0M	58.0M	24.0M	17.6M	17.7M	7.6M	33.5M	20.6M	19.6M	15.7M	10.9M	6.9M	576,800	-505,500
Other Income	35.4M	39.0M	31.7M	43.9M	45.3M	17.3M	9.2M	16.6M	--	--	--	--	--	--
Income Before Tax	125.0M	305.0M	789.0M	1.2B	970.0M	693.0M	597.0M	502.0M	401.0M	302.0M	284.0M	242.0M	199.0M	154.0M
Income Tax	5.9M	689,900	87.4M	185.0M	148.0M	127.0M	114.0M	93.2M	71.8M	51.4M	57.7M	49.3M	41.1M	33.1M
+Net Income	119.0M	305.0M	702.0M	1.0B	821.0M	566.0M	483.0M	408.0M	329.0M	251.0M	226.0M	193.0M	158.0M	121.0M
Net Margin %	4.7%	10.5%	19.5%	25.2%	22.2%	17.6%	18.0%	20.7%	22.1%	23.6%	24.2%	24.8%	26.1%	23.2%
Net Income Attributable	127.0M	313.0M	708.0M	957.0M	794.0M	525.0M	445.0M	374.0M	312.0M	251.0M	226.0M	193.0M	158.0M	120.0M
Minority Interest	-8.0M	-7.9M	-6.5M	45.6M	27.4M	40.4M	38.0M	34.3M	16.9M	-81,100	--	--	--	230,300
Eps Basic	0.21	0.51	1.17	1.73	1.43	0.95	0.80	0.67	0.56	0.45	1.52	1.30	1.07	0.81
Eps Diluted	0.21	0.51	1.17	1.72	1.42	0.94	0.80	0.67	0.56	0.45	1.52	1.30	1.07	0.81

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	671.0M	836.0M	587.0M	637.0M	612.0M	444.0M	442.0M	344.0M	154.0M	201.0M	178.0M	106.0M	117.0M	105.0M
Trading Financial Assets	60.1M	311.0M	664.0M	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	1.6B	1.8B	2.1B	1.9B	2.0B	1.9B	1.5B	1.1B	790.0M	579.0M	388.0M	232.0M	150.0M	132.0M
Notes Receivable	17.1M	20.3M	39.3M	29.6M	45.9M	55.9M	68.5M	2.4M	1.2M	--	500,000	600,000	400,000	--
Notes And Accounts Receivable	1.6B	1.8B	2.1B	1.9B	2.1B	2.0B	1.5B	1.1B	791.0M	579.0M	388.0M	233.0M	150.0M	132.0M
Prepayments	157.0M	194.0M	146.0M	107.0M	134.0M	148.0M	152.0M	118.0M	81.7M	61.5M	41.9M	24.3M	21.7M	15.2M
Inventory	902.0M	907.0M	1.0B	1.1B	1.1B	852.0M	731.0M	548.0M	359.0M	267.0M	191.0M	173.0M	135.0M	94.5M
Total Current Assets	3.6B	4.2B	4.7B	3.9B	4.0B	3.5B	3.0B	2.3B	1.7B	1.8B	810.0M	548.0M	429.0M	359.0M
Long Term Equity Investment	--	--	2.0M	1.8M	1.9M	941,300	--	--	--	25.8M	8.1M	5.8M	5.2M	5.3M
Fixed Assets	--	2.2B	2.0B	1.9B	1.7B	1.6B	1.1B	851.0M	332.0M	283.0M	252.0M	215.0M	184.0M	42.9M
Fixed Assets Total	2.3B	2.2B	2.0B	1.9B	1.7B	1.6B	1.1B	851.0M	332.0M	283.0M	252.0M	215.0M	184.0M	42.9M
Construction In Progress	--	714.0M	504.0M	77.0M	29.8M	15.7M	187.0M	196.0M	454.0M	234.0M	112.0M	35.2M	3.3M	91.1M
Construction In Progress Total	1.1B	714.0M	504.0M	77.0M	29.8M	15.7M	187.0M	196.0M	454.0M	234.0M	112.0M	35.2M	3.3M	91.1M
Intangible Assets	375.0M	283.0M	269.0M	195.0M	188.0M	105.0M	73.8M	80.6M	68.5M	18.3M	13.8M	14.0M	2.4M	2.5M
Long Term Deferred Expenses	3.1M	4.9M	8.3M	9.3M	6.1M	8.4M	9.1M	8.9M	5.5M	2.2M	1.1M	745,000	--	--
Total Non Current Assets	4.3B	3.9B	3.5B	2.7B	2.3B	2.0B	1.6B	1.3B	949.0M	592.0M	406.0M	289.0M	201.0M	146.0M
Total Assets	8.0B	8.1B	8.2B	6.6B	6.4B	5.5B	4.6B	3.6B	2.7B	2.4B	1.2B	837.0M	630.0M	505.0M
Short Term Borrowings	255.0M	145.0M	248.0M	531.0M	922.0M	1.2B	944.0M	550.0M	130.0M	66.2M	164.0M	131.0M	106.0M	83.0M
Accounts Payable	210.0M	285.0M	379.0M	310.0M	346.0M	262.0M	199.0M	117.0M	81.3M	65.4M	35.4M	41.6M	18.7M	26.5M
Advance Receipts	--	--	--	--	--	36.8M	36.2M	18.4M	21.2M	4.7M	11.6M	10.7M	25.8M	27.1M
Contract Liabilities	72.0M	72.4M	74.4M	77.0M	88.9M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.2B	1.1B	1.1B	1.3B	1.8B	1.8B	1.4B	831.0M	391.0M	290.0M	286.0M	231.0M	185.0M	191.0M
Long Term Borrowings	184.0M	162.0M	286.0M	424.0M	330.0M	200.0M	250.0M	120.0M	--	69.0M	127.0M	--	--	--
Total Non Current Liabilities	357.0M	387.0M	556.0M	712.0M	562.0M	350.0M	307.0M	140.0M	23.8M	82.0M	138.0M	1.3M	1.4M	2.1M
Total Liabilities	1.6B	1.5B	1.6B	2.0B	2.4B	2.2B	1.7B	970.0M	415.0M	372.0M	424.0M	233.0M	187.0M	193.0M
Paid In Capital	612.0M	612.0M	612.0M	556.0M	557.0M	558.0M	558.0M	558.0M	558.0M	186.0M	149.0M	149.0M	149.0M	45.0M
Capital Reserve	1.8B	1.8B	1.8B	280.0M	369.0M	444.0M	486.0M	531.0M	585.0M	970.0M	10.6M	10.6M	10.6M	28.6M
Surplus Reserve	306.0M	306.0M	306.0M	278.0M	272.0M	195.0M	153.0M	114.0M	82.5M	58.3M	40.8M	29.3M	20.4M	12.8M
Retained Earnings	3.9B	3.8B	3.7B	3.3B	2.6B	2.0B	1.6B	1.3B	1.0B	780.0M	592.0M	416.0M	263.0M	225.0M
Minority Equity	54.6M	227.0M	236.0M	243.0M	209.0M	201.0M	170.0M	112.0M	39.9M	5.3M	--	--	--	--
Equity Attributable	6.4B	6.4B	6.3B	4.3B	3.8B	3.1B	2.7B	2.5B	2.2B	2.0B	792.0M	604.0M	443.0M	312.0M
Total Equity	6.4B	6.6B	6.5B	4.5B	4.0B	3.3B	2.9B	2.6B	2.3B	2.0B	792.0M	604.0M	443.0M	312.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	3.0B	3.4B	3.8B	5.2B	4.2B	3.3B	2.7B	2.0B	1.5B	1.1B	996.0M	854.0M	721.0M	609.0M
Tax Refunds Received	26.4M	92.1M	16.3M	13.1M	19.5M	8.1M	790,000	1.0M	3.1M	651,600	--	--	--	--
Total Operating Cash Inflow	3.1B	3.6B	3.8B	5.2B	4.3B	3.3B	2.8B	2.0B	1.6B	1.1B	999.0M	855.0M	725.0M	620.0M
Cash Paid For Goods	1.3B	1.5B	1.7B	2.4B	2.1B	1.9B	1.7B	1.3B	974.0M	655.0M	548.0M	487.0M	402.0M	343.0M
Cash Paid To Employees	529.0M	506.0M	460.0M	410.0M	313.0M	297.0M	269.0M	227.0M	188.0M	151.0M	114.0M	86.8M	72.2M	53.8M
Taxes Paid	187.0M	229.0M	328.0M	425.0M	339.0M	256.0M	234.0M	189.0M	188.0M	130.0M	129.0M	117.0M	91.1M	78.7M
Total Operating Cash Outflow	2.4B	2.7B	3.0B	3.6B	3.2B	2.8B	2.6B	1.9B	1.5B	1.0B	884.0M	757.0M	614.0M	535.0M
Operating Cash Flow	634.0M	902.0M	843.0M	1.6B	1.1B	460.0M	194.0M	79.0M	49.3M	33.2M	115.0M	98.4M	111.0M	85.5M
Total Investing Cash Inflow	866.0M	2.2B	1.7B	2.5M	3.8M	1.2M	111.0M	635.0M	2.5B	14.2M	2.2M	4.6M	8.0M	10.4M
Total Investing Cash Outflow	1.5B	2.7B	3.6B	689.0M	506.0M	516.0M	530.0M	871.0M	2.6B	884.0M	161.0M	108.0M	69.0M	86.0M
Investing Cash Flow	-677.0M	-503.0M	-1.8B	-687.0M	-503.0M	-514.0M	-419.0M	-236.0M	-83.0M	-870.0M	-159.0M	-103.0M	-61.0M	-75.5M
Cash From Borrowings	686.0M	609.0M	605.0M	763.0M	1.1B	1.4B	1.2B	730.0M	223.0M	189.0M	427.0M	233.0M	202.0M	84.9M
Dividends And Interest Paid	157.0M	247.0M	319.0M	298.0M	183.0M	157.0M	127.0M	77.0M	54.1M	54.3M	47.7M	37.9M	34.7M	5.5M
Debt Repayments	613.0M	495.0M	897.0M	1.1B	1.2B	1.1B	686.0M	259.0M	226.0M	281.0M	267.0M	209.0M	204.0M	46.3M
Total Financing Cash Inflow	686.0M	609.0M	2.2B	763.0M	1.1B	1.4B	1.2B	769.0M	237.0M	1.2B	427.0M	233.0M	202.0M	84.9M
Total Financing Cash Outflow	813.0M	761.0M	1.2B	1.7B	1.5B	1.3B	960.0M	378.0M	281.0M	336.0M	314.0M	247.0M	239.0M	51.8M
Financing Cash Flow	-127.0M	-153.0M	930.0M	-895.0M	-433.0M	94.3M	277.0M	391.0M	-43.6M	856.0M	112.0M	-13.3M	-36.7M	33.1M
Net Change In Cash	-170.0M	247.0M	-51.4M	33.0M	153.0M	39.6M	52.4M	234.0M	-77.4M	19.1M	68.4M	-17.8M	13.2M	43.2M
Ending Cash Balance	641.0M	811.0M	564.0M	616.0M	583.0M	430.0M	390.0M	338.0M	104.0M	182.0M	163.0M	94.1M	112.0M	98.7M
Capex	963.0M	878.0M	988.0M	602.0M	501.0M	505.0M	530.0M	462.0M	389.0M	221.0M	161.0M	108.0M	69.0M	83.0M